Structures by: Chitra S.
Total: 18
2-[(4-Chlorophenyl)(2-phenyl-1<i>H</i>-indol-3-yl)methyl]cyclohexan-1-one
C27H24ClNO
IUCrData (2016) 1, 4 x160644
a=7.2562(2)Å b=16.4818(5)Å c=18.0306(6)Å
α=90° β=95.149(2)° γ=90°
4-(4-chlorophenyl)-6-(4-methylphenyl)-2,3,3a, 4-tetrahydro-1H- pyrido(3,2,1-jk)carbazole
C28H24ClN
Green Chemistry (2011) 13, 10 2777
a=9.3488(17)Å b=9.504(3)Å c=13.036(3)Å
α=74.37(2)° β=72.819(17)° γ=84.648(18)°
Dihydropyrimidine
C14H16N2O2S
Acta Crystallographica Section E (2009) 65, 12 o3036
a=12.0415(2)Å b=6.22190(10)Å c=18.0192(3)Å
α=90° β=100.9010(10)° γ=90°
Dihydropyrimidine
C13H13ClN2OS
Acta Crystallographica Section E (2009) 65, 12 o3068
a=7.2346(12)Å b=22.585(3)Å c=8.0941(15)Å
α=90° β=106.177(17)° γ=90°
Dihydropyrazine
C23H20N2
Acta Crystallographica Section E (2009) 65, 3 o546
a=10.4406(10)Å b=10.5753(7)Å c=11.0810(13)Å
α=93.439(8)° β=114.161(10)° γ=118.343(9)°
Dihydropyrimidine-2(1H)-thione
C13H13ClN2OS
Acta Crystallographica Section E (2009) 65, 3 o564-o565
a=7.2389(6)Å b=8.2304(7)Å c=12.9038(11)Å
α=73.366(7)° β=89.373(7)° γ=72.613(7)°
Dihydropyrimidinone
C14H16N2O3
Acta Crystallographica Section E (2009) 65, 1 o23
a=23.7948(12)Å b=7.9905(3)Å c=14.4757(7)Å
α=90° β=108.305(5)° γ=90°
Dihydropyrimidinone
C13H13ClN2O2
Acta Crystallographica Section E (2008) 64, 12 o2474-o2475
a=14.5364(8)Å b=12.1587(5)Å c=7.0780(4)Å
α=90° β=90° γ=90°
Triphenylpyrazine
C22H16N2
Acta Crystallographica Section E (2009) 65, 1 o106
a=15.563(2)Å b=6.2005(9)Å c=16.845(3)Å
α=90° β=90° γ=90°
Dihydropyrimidin-2(1H)-thione
C13H14N2OS
Acta Crystallographica Section E (2010) 66, 9 o2280
a=7.8849(10)Å b=7.2054(5)Å c=21.555(3)Å
α=90° β=94.401(12)° γ=90°
1-(2-Naphthyl)-3-phenyl-3-(4,5,6,7-tetrahydro-1,2,3-benzoselenadiazol- 4-yl)propan-1-one
C25H22N2OSe
Acta Crystallographica Section E (2011) 67, 8 o2010-o2011
a=8.0600(4)Å b=10.1215(5)Å c=13.0827(6)Å
α=81.479(4)° β=76.478(4)° γ=82.087(4)°
2,3-dihydropyrazine
C23H19ClN2
Acta Crystallographica Section E (2011) 67, 10 o2598
a=10.5675(8)Å b=19.7014(9)Å c=10.4207(7)Å
α=90° β=118.479(9)° γ=90°
4-{(4-Chlorophenyl)[4-(4-methylphenyl)-1,2,3-selenadiazol-5-yl]methyl}-4,5,6,7- tetrahydro-1,2,3-benzoselenadiazole
C22H19ClN4Se2
Acta Crystallographica Section E (2011) 67, 6 o1421-o1422
a=9.7226(18)Å b=12.969(4)Å c=17.690(3)Å
α=90.00° β=100.959(19)° γ=90.00°
3-(4-Methylphenyl)-1-phenyl-3-(4,5,6,7-tetrahydro-1,2,3-benzoselenadiazol- 4-yl)propan-1-one
C22H22N2OSe
Acta Crystallographica Section E (2011) 67, 7 o1660-o1661
a=8.1485(9)Å b=9.7929(9)Å c=12.1234(13)Å
α=98.707(9)° β=96.387(9)° γ=94.792(9)°
2,3-dihydropyrazine
C24H22N2
Acta Crystallographica Section E (2012) 68, 11 o3084
a=8.1986(5)Å b=11.8211(6)Å c=19.6686(7)Å
α=90° β=93.638(4)° γ=90°
Pyrazine
C24H20N2
Acta Crystallographica Section E (2012) 68, 10 o3003
a=9.2327(9)Å b=9.8708(11)Å c=10.6787(14)Å
α=79.604(10)° β=70.351(11)° γ=87.848(8)°
Dihydropyrimidin-2(1H)-thione
C13H13FN2OS
Acta Crystallographica Section E (2012) 68, 9 o2625
a=7.1775(11)Å b=8.1099(13)Å c=12.490(2)Å
α=103.529(15)° β=91.933(14)° γ=106.971(14)°
Dihydropyrimidin-2(1H)-thione
C16H20N2OS
Acta Crystallographica Section E (2012) 68, 9 o2641
a=26.8413(5)Å b=9.5657(2)Å c=12.0764(2)Å
α=90° β=90.370(2)° γ=90°